Jpmorgan Chase & CO Eton Pharmaceuticals, Inc. Transaction History

Jpmorgan Chase & CO

$1.22 Trillion
Q3 2024

A detailed history of Jpmorgan Chase & CO transactions in Eton Pharmaceuticals, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 723 shares of ETON stock, worth $9,507. This represents 0.0% of its overall portfolio holdings.

Number of Shares

723

Holding current value

$9,507

% of portfolio

0.0%

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	BUY	$3.28 - $6.0 $2,371 - $4,338	723 New	723 $4,000
Q1 2024 Dec 26, 2024	BUY	$3.48 - $5.03 $64,143 - $92,712	18,432 Added 2549.38%	19,155 $71,000
Q1 2024 May 10, 2024	BUY	$3.48 - $5.03 $66,659 - $96,349	19,155 New	19,155 $71,000
Q2 2023 Aug 11, 2023	BUY	$3.32 - $4.04 $19,624 - $23,880	5,911 New	5,911 $20,000
Q3 2022 Nov 14, 2022	BUY	$2.04 - $3.03 $18,672 - $27,733	9,153 Added 221.89%	13,278 $28,000
Q2 2022 Aug 11, 2022	SELL	$2.55 - $4.38 $51,377 - $88,248	-20,148 Reduced 83.01%	4,125 $11,000
Q1 2022 May 11, 2022	BUY	$3.43 - $4.69 $83,256 - $113,840	24,273 New	24,273 $106,000

Others Institutions Holding ETON

# of Institutions

Shares Held

9.44M

Call Options Held

261K

Put Options Held

500

Opaleye Management Inc. Boston, MA

2.78M
Shares

$36.6 Million
3.05% of portfolio
Vanguard Group Inc Valley Forge, PA

1.03M
Shares

$13.5 Million
0.0% of portfolio
Nantahala Capital Management, LLC New Canaan, CT

999K
Shares

$13.1 Million
0.36% of portfolio
Westside Investment Management, Inc.

619K
Shares

$8.14 Million
0.79% of portfolio
Acuitas Investments, LLC

580K
Shares

$7.63 Million
1.66% of portfolio

View Full List

About Eton Pharmaceuticals, Inc.

Ticker ETON
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,297,000
Market Cap $333M
Description
Eton Pharmaceuticals, Inc., a specialty pharmaceutical company, focuses on developing and commercializing pharmaceutical products for rare diseases. The company offers Biorphen, a phenylephrine injection for the treatment of clinically important hypotension resulting primarily from vasodilation in the setting of anesthesia; Carglumic Acid for th...

More about ETON

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account